Email this article PRIMENENIE KOMBINIROVANNYKh ORAL'NYKh KONTRATsEPTIVOV, SODERZhAShchIKh DROSPIRENON, PRI LEChENII SINDROMA POLIKISTOZNYKh YaIChNIKOV
- Authors: Raykova A.A1
-
Affiliations:
- ГБОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова»
- Issue: Vol 3, No 4 (2016)
- Pages: 214-215
- Section: Original study articles
- URL: https://ogarev-online.ru/2313-8726/article/view/35393
- ID: 35393
Cite item
Abstract
Polycystic ovary syndrome is one of the most studied pathologies in gynecology, but the etiology and pathogenesis has not been fully elucidated. An important role in the treatment of combined oral contraceptives play a latest-generation progestogen, such as drospirenone. The use of combined oral contraceptives with antiandrogen activity justified pathogenetically.
Full Text
##article.viewOnOriginalSite##About the authors
A. A Raykova
ГБОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова»г. Москва
References
Supplementary files
